Sporanox

GPTKB entity

Statements (56)
Predicate Object
gptkbp:instance_of gptkb:drug
gptkbp:activities inhibits fungal cell membrane synthesis
gptkbp:approves gptkb:FDA
gptkbp:availability generic version available
gptkbp:brand gptkb:itraconazole
gptkbp:class triazole antifungal
gptkbp:clinical_trial Phase IV
short-term treatment
Phase III
long-term treatment
gptkbp:contraindication pregnancy
severe liver disease
congestive heart failure
lactation
concurrent use with certain medications
gptkbp:dosage_form oral
gptkbp:formulation gptkb:beer
oral solution
https://www.w3.org/2000/01/rdf-schema#label Sporanox
gptkbp:indication aspergillosis
onychomycosis
histoplasmosis
blastomycosis
gptkbp:ingredients gptkb:itraconazole
gptkbp:interacts_with CY P3 A4 inducers
CY P3 A4 inhibitors
gptkbp:is_used_for treating fungal infections
gptkbp:lifespan approximately 34 hours
gptkbp:manager oral
gptkbp:manufacturer gptkb:Janssen_Pharmaceuticals
gptkbp:marketed_as gptkb:legislation
gptkb:United_States
gptkb:Native_American_tribe
gptkbp:packaging gptkb:beer
blister pack
gptkbp:products gptkb:posaconazole
gptkb:fluconazole
voriconazole
gptkbp:requires prescription only
gptkbp:rounds urine
feces
gptkbp:scholarships avoid alcohol
monitor liver function
report any unusual symptoms
gptkbp:side_effect dizziness
headache
nausea
abdominal pain
heart failure
liver toxicity
skin rash
hypersensitivity reactions
elevated liver enzymes
gptkbp:storage room temperature
gptkbp:bfsParent gptkb:itraconazole
gptkbp:bfsLayer 5